Brief: Medivir Presents MIV-818 Data At ASCO Gastrointestinal Cancers Symposium

Medivir AB

12/01/2021 07:35

Jan 12 (Reuters) - Medivir AB  MVIRb.ST :
    * MEDIVIR PRESENTS MIV-818 DATA AT ASCO GASTROINTESTINAL
CANCERS
SYMPOSIUM
    * RESULTS FROM COMPLETED PHASE IA INTRA-PATIENT DOSE
ESCALATION
PART OF STUDY SHOW THAT MIV-818 HAS AN ACCEPTABLE SAFETY AND
TOLERABILITY PROFILE AND A SELECTIVE EFFECT ON LIVER CANCER
CELLS

Source text for Eikon:  ID:nWkr64kMWm 
Further company coverage:  MVIRb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))